Latest Australian Strategic Materials (ASX:ASM) News

Australian Strategic Materials (ASM) has postponed its shareholder Scheme Meetings to early August 2026, following Energy Fuels’ major financing and acquisition moves. The updated timetable awaits court and regulatory approvals, with the ASM board maintaining its unanimous recommendation.

Australian Strategic Materials has delayed key shareholder meetings amid Energy Fuels’ $1.9 billion acquisition of Vacuumschmelze, prompting a supplementary disclosure for ASM securityholders.

Australian Strategic Materials (ASM) confirms the Independent Expert’s continued support for Energy Fuels’ acquisition scheme, despite a notable decline in Energy Fuels’ share price. ASM directors remain unanimously in favour as scheme meetings approach.

Battery tech, biotech and balance-sheet repair drove the biggest gains this week, while guidance cuts and weak post-halt trading hurt several names. Deal-making and fresh equity funding stayed busy, especially in rare earths, defence and gold.

Coal, gold and critical minerals names drove the biggest share moves this week, but strong project news did not always lead to lasting gains. Several stocks jumped on funding, deals and study results, while others gave back early gains as traders locked in profit or worried about dilution.

Australian Strategic Materials Limited (ASM) shareholders are set to vote on a scheme of arrangement for Energy Fuels Inc. to acquire 100% of ASM shares and options, offering a significant premium and exposure to a vertically integrated rare earth supply chain.

Australian Strategic Materials reports a 70% surge in NdFeB alloy production, installs pilot heavy rare earth furnace, and progresses its acquisition by Energy Fuels with regulatory approvals underway.

Energy Fuels has secured Foreign Investment Review Board approval to acquire Australian Strategic Materials, clearing a major regulatory hurdle. The deal now awaits shareholder and court approvals, with implementation targeted for early July.

A single biotech result reset expectations in minutes, while gold and critical minerals kept investors busy on deals, drilling and funding. The week’s biggest moves came from one trial being stopped, a miner losing altitude after heavy selling, and a U.S. tungsten stock hit hard on risk-off trading.

Gold names split cleanly this week: one stock rocketed on tangible production progress, while another cratered as selling overwhelmed a big plan. Critical minerals kept drawing attention, but several gap-ups didn’t hold once early buyers took profits.

Australian Strategic Materials and Energy Fuels have amended their acquisition deal, replacing a special dividend with a direct cash payment to ASM shareholders, while maintaining the original share swap terms.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.